Danone S.A.

2 days ago · globenewswire.com

Press release – Paris, September 21, 2026, at 6:00 PM CEST Danone successfully issues a triple-tranche bond totaling €1.5 billion          Danone announces that it has today launched a triple-tranche bond offering with a total amount of €1.5 billion, comprising: a €500 million tranche of 18-month notes, carrying a floating coupon of 3-month Euribor +0.30%; a €500 million tranche of 5-year notes, carrying a 4.0910 % coupon; a €500 million tranche of 9-year notes, carrying a 4.4180 % coupon. In line with the company's active liquidity management, this issue enables Danone to enhance its funding flexibility while extending the maturity of its debt.

6 days ago · defenseworld.net

Danone (OTCMKTS:DANOY - Get Free Report)'s share price reached a new 52-week low on Thursday. The stock traded as low as $13.91 and last traded at $13.96, with a volume of 302875 shares traded. The stock had previously closed at $14.1650. Analyst Ratings Changes Several equities research analysts recently issued reports on the company.

10 days ago · globenewswire.com

DANONE French Société anonyme with a capital of € 170,834,294.25 Registered Office: 59-61, rue La Fayette, 75009 Paris. Registered with the Paris Commerce and Company Registry under number 552 032 534 Information on the total number of voting rights and shares in compliance with Article L.

11 months ago · seekingalpha.com

Danone S.A. (OTCQX:DANOY) Q3 2025 Sales Call October 28, 2025 3:00 AM EDT Company Participants Mathilde Rodie - Head of Investor Relations & Sustainable Finance Juergen Esser - Chief Financial, Technology & Data Officer and Group Deputy CEO Conference Call Participants Guillaume Gerard Delmas - UBS Investment Bank, Research Division Warren Ackerman - Barclays Bank PLC, Research Division Jeremy Fialko - HSBC Global Investment Research Celine Pannuti - JPMorgan Chase & Co, Research Division Jon Cox - Kepler Cheuvreux, Research Division Charlie Higgs - Rothschild & Co Redburn, Research Division Tom Sykes - Deutsche Bank AG, Research Division David Roux - Morgan Stanley, Research Division Presentation Operator Good day, and thank you for standing by.

11 months ago · wsj.com

The company posted sales growth of 4.8% on a like-for-like basis, fueled by accelerating growth in China despite a continued slowdown in North America.

11 months ago · globenewswire.com

2025 Third-Quarter Sales Press release – Paris, October 28, 2025, at 7:30 AM CET Strong and consistent growth in Q3, led by volume/mix Sales reached €6,876m in Q3 2025, up +4.8% on a like-for-like (LFL) basis Strong volume/mix, up +3.2%, and price up +1.6%; quality growth across all categories Outstanding performance in China, North Asia & Oceania, with strong momentum in all categories Continued step-up in Europe, driven by volume/mix Softer growth in North America, despite sustained momentum in high protein 2025 guidance confirmed, in line with mid-term ambition: like-for-like sales growth expected between +3% and +5%, with recurring operating income growing faster than sales € million except % Q3 2024 Q3 2025 Reported change LFL sales growth Volume/mix growth 9M 2024 9M 2025 Reported change LFL sales growth Volume/mix growth   BY GEOGRAPHICAL ZONE                     Europe 2,427 2,481 +2.2% +2.6% +2.1% 7,210 7,375 +2.3% +2.3% +2.2%   North America 1,611 1,577 -2.1% +1.5% +0.3% 4,943 4,757 -3.8% +2.5% +1.0%   China, North Asia & Oceania 967 1,032 +6.7% +13.8% +15.1% 2,808 3,048 +8.6% +12.1% +13.0%   Latin America 706 676 -4.2% +4.3% -2.3% 2,265 2,066 -8.8% +5.2% -2.5%   Asia, Middle East & Africa 1,115 1,111 -0.4% +6.8% +2.6% 3,350 3,332 -0.5% +4.8% +1.0%   BY CATEGORY                     EDP 3,283 3,255 -0.9% +3.5% +1.7% 10,066 9,853 -2.1% +3.4% +1.8%   Specialized Nutrition 2,189 2,299 +5.0% +8.3% +6.5% 6,599 6,904 +4.6% +7.5% +5.5%   Waters 1,354 1,322 -2.3% +2.3% +1.3% 3,910 3,822 -2.2% +1.8% +0.6%                         TOTAL 6,826 6,876 +0.7% +4.8% +3.2% 20,575 20,578 +0.0% +4.4% +2.8%   1 Antoine de Saint-Affrique: CEO statement We continued to deliver consistent, quality growth this quarter, with volume/mix being the primary growth driver across our categories, confirming the strength and the relevance of our health-focused portfolio. We are particularly pleased with the step-by-step improvement in Europe, where volume/mix has now been positive for eight consecutive quarters, while CNAO delivered another outstanding performance across all categories.